These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
515 related articles for article (PubMed ID: 18171713)
1. Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis. Chen J; Saxena G; Mungrue IN; Lusis AJ; Shalev A Diabetes; 2008 Apr; 57(4):938-44. PubMed ID: 18171713 [TBL] [Abstract][Full Text] [Related]
2. Lack of TXNIP protects beta-cells against glucotoxicity. Shalev A Biochem Soc Trans; 2008 Oct; 36(Pt 5):963-5. PubMed ID: 18793170 [TBL] [Abstract][Full Text] [Related]
3. Insulin counteracts glucotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus pancreatic islets. Shaked M; Ketzinel-Gilad M; Ariav Y; Cerasi E; Kaiser N; Leibowitz G Diabetologia; 2009 Apr; 52(4):636-44. PubMed ID: 19214472 [TBL] [Abstract][Full Text] [Related]
4. Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid-induced ER stress-mediated beta-cell death. Chen J; Fontes G; Saxena G; Poitout V; Shalev A Diabetes; 2010 Feb; 59(2):440-7. PubMed ID: 19875615 [TBL] [Abstract][Full Text] [Related]
5. Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis. Minn AH; Hafele C; Shalev A Endocrinology; 2005 May; 146(5):2397-405. PubMed ID: 15705778 [TBL] [Abstract][Full Text] [Related]
7. SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice. Qin K; Zhang N; Zhang Z; Nipper M; Zhu Z; Leighton J; Xu K; Musi N; Wang P Diabetologia; 2018 Apr; 61(4):906-918. PubMed ID: 29322219 [TBL] [Abstract][Full Text] [Related]
8. Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes. Chen J; Hui ST; Couto FM; Mungrue IN; Davis DB; Attie AD; Lusis AJ; Davis RA; Shalev A FASEB J; 2008 Oct; 22(10):3581-94. PubMed ID: 18552236 [TBL] [Abstract][Full Text] [Related]
9. Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein. Chen J; Cha-Molstad H; Szabo A; Shalev A Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1133-9. PubMed ID: 19258488 [TBL] [Abstract][Full Text] [Related]
10. Preventing β-cell loss and diabetes with calcium channel blockers. Xu G; Chen J; Jing G; Shalev A Diabetes; 2012 Apr; 61(4):848-56. PubMed ID: 22442301 [TBL] [Abstract][Full Text] [Related]
11. Histone acetylation of glucose-induced thioredoxin-interacting protein gene expression in pancreatic islets. Bompada P; Atac D; Luan C; Andersson R; Omella JD; Laakso EO; Wright J; Groop L; De Marinis Y Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):82-91. PubMed ID: 27989964 [TBL] [Abstract][Full Text] [Related]
12. W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway. Li T; Lin GY; Zhong L; Zhou Y; Wang J; Zhu Y; Feng Y; Cai XQ; Liu Q; Nosjean O; Boutin JA; Renard P; Yang DH; Wang MW Acta Pharmacol Sin; 2017 Jul; 38(7):1024-1037. PubMed ID: 28502980 [TBL] [Abstract][Full Text] [Related]
13. Exenatide inhibits beta-cell apoptosis by decreasing thioredoxin-interacting protein. Chen J; Couto FM; Minn AH; Shalev A Biochem Biophys Res Commun; 2006 Aug; 346(3):1067-74. PubMed ID: 16782054 [TBL] [Abstract][Full Text] [Related]
14. Palmitate and insulin counteract glucose-induced thioredoxin interacting protein (TXNIP) expression in insulin secreting cells via distinct mechanisms. Panse M; Kluth O; Lorza-Gil E; Kaiser G; Mühlbauer E; Schürmann A; Häring HU; Ullrich S; Gerst F PLoS One; 2018; 13(5):e0198016. PubMed ID: 29813102 [TBL] [Abstract][Full Text] [Related]
15. Mice lacking thioredoxin-interacting protein provide evidence linking cellular redox state to appropriate response to nutritional signals. Hui TY; Sheth SS; Diffley JM; Potter DW; Lusis AJ; Attie AD; Davis RA J Biol Chem; 2004 Jun; 279(23):24387-93. PubMed ID: 15047687 [TBL] [Abstract][Full Text] [Related]
16. Transcription factor Ets1 regulates expression of thioredoxin-interacting protein and inhibits insulin secretion in pancreatic β-cells. Luo Y; He F; Hu L; Hai L; Huang M; Xu Z; Zhang J; Zhou Z; Liu F; Dai YS PLoS One; 2014; 9(6):e99049. PubMed ID: 24897113 [TBL] [Abstract][Full Text] [Related]
17. Involvement of thioredoxin-interacting protein (TXNIP) in glucocorticoid-mediated beta cell death. Reich E; Tamary A; Sionov RV; Melloul D Diabetologia; 2012 Apr; 55(4):1048-57. PubMed ID: 22246375 [TBL] [Abstract][Full Text] [Related]
18. Possible role for the thioredoxin system in the protective effects of probucol in the pancreatic islets of diabetic rats. Liu JH; Liu DF; Wang NN; Lin HL; Mei X Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):528-33. PubMed ID: 21615774 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-200 is induced by thioredoxin-interacting protein and regulates Zeb1 protein signaling and beta cell apoptosis. Filios SR; Xu G; Chen J; Hong K; Jing G; Shalev A J Biol Chem; 2014 Dec; 289(52):36275-83. PubMed ID: 25391656 [TBL] [Abstract][Full Text] [Related]
20. Cytokines Regulate β-Cell Thioredoxin-interacting Protein (TXNIP) via Distinct Mechanisms and Pathways. Hong K; Xu G; Grayson TB; Shalev A J Biol Chem; 2016 Apr; 291(16):8428-39. PubMed ID: 26858253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]